Evaluation of glycemic control following discontinuation of an intensive insulin protocol

Quinn A. Czosnowski, Joseph Swanson, Bob L. Lobo, Joyce Broyles, Paul R. Deaton, Christopher K. Finch

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Backgrounds: Intensive insulin protocols (IIPs) have been demonstrated to reduce morbidity and mortality in critically ill patients. Currently, there are no published studies evaluating glycemic control after discontinuation of an IIP. Objective: The purpose of this study was to compare blood glucose (BG) control during an IIP and for 5 days following its discontinuation (follow-up period). Methods: The study was a retrospective review of intensive care unit patients who received an IIP for ≥24 hours. Data were collected during the last 12 hours of the IIP and subsequent follow-up period. Results: For all 65 included patients, the mean ± standard deviation for BG on the IIP was 123 ± 26 mg/dL versus 168 ± 50 mg/dL following discontinuation of the IIP (P < 0.001). The median (interquartile range) insulin that was administered decreased from 40 (22-65) units on the IIP to 8 (0-18) units after the IIP was stopped (P < 0.001). The mean daily BG during the follow-up period was significantly higher than that during the IIP (P < 0.001). Additionally, an insulin requirement of >20 units during the last 12 hours of the IIP was identified as a risk factor for poor glycemic control during the follow-up period (odds ratio: 4.62; 95% confidence interval: 1.17-18.17). Conclusions: This study demonstrates a significant increase in BG following discontinuation of an IIP. Higher insulin requirements during the last 12 hours of an IIP were identified as an independent risk factor for poor glycemic control following the IIP. A standardized insulin transition protocol may help better control BG after discontinuation of an IIP.

Original languageEnglish (US)
Pages (from-to)28-34
Number of pages7
JournalJournal of Hospital Medicine
Volume4
Issue number1
DOIs
StatePublished - Jun 2 2009

Fingerprint

Insulin
Blood Glucose
Critical Illness
Intensive Care Units
Odds Ratio
Confidence Intervals
Morbidity
Mortality

All Science Journal Classification (ASJC) codes

  • Leadership and Management
  • Fundamentals and skills
  • Health Policy
  • Care Planning
  • Assessment and Diagnosis

Cite this

Evaluation of glycemic control following discontinuation of an intensive insulin protocol. / Czosnowski, Quinn A.; Swanson, Joseph; Lobo, Bob L.; Broyles, Joyce; Deaton, Paul R.; Finch, Christopher K.

In: Journal of Hospital Medicine, Vol. 4, No. 1, 02.06.2009, p. 28-34.

Research output: Contribution to journalArticle

Czosnowski, Quinn A. ; Swanson, Joseph ; Lobo, Bob L. ; Broyles, Joyce ; Deaton, Paul R. ; Finch, Christopher K. / Evaluation of glycemic control following discontinuation of an intensive insulin protocol. In: Journal of Hospital Medicine. 2009 ; Vol. 4, No. 1. pp. 28-34.
@article{4d7ccc4a297b4090a6906c0c6f503e95,
title = "Evaluation of glycemic control following discontinuation of an intensive insulin protocol",
abstract = "Backgrounds: Intensive insulin protocols (IIPs) have been demonstrated to reduce morbidity and mortality in critically ill patients. Currently, there are no published studies evaluating glycemic control after discontinuation of an IIP. Objective: The purpose of this study was to compare blood glucose (BG) control during an IIP and for 5 days following its discontinuation (follow-up period). Methods: The study was a retrospective review of intensive care unit patients who received an IIP for ≥24 hours. Data were collected during the last 12 hours of the IIP and subsequent follow-up period. Results: For all 65 included patients, the mean ± standard deviation for BG on the IIP was 123 ± 26 mg/dL versus 168 ± 50 mg/dL following discontinuation of the IIP (P < 0.001). The median (interquartile range) insulin that was administered decreased from 40 (22-65) units on the IIP to 8 (0-18) units after the IIP was stopped (P < 0.001). The mean daily BG during the follow-up period was significantly higher than that during the IIP (P < 0.001). Additionally, an insulin requirement of >20 units during the last 12 hours of the IIP was identified as a risk factor for poor glycemic control during the follow-up period (odds ratio: 4.62; 95{\%} confidence interval: 1.17-18.17). Conclusions: This study demonstrates a significant increase in BG following discontinuation of an IIP. Higher insulin requirements during the last 12 hours of an IIP were identified as an independent risk factor for poor glycemic control following the IIP. A standardized insulin transition protocol may help better control BG after discontinuation of an IIP.",
author = "Czosnowski, {Quinn A.} and Joseph Swanson and Lobo, {Bob L.} and Joyce Broyles and Deaton, {Paul R.} and Finch, {Christopher K.}",
year = "2009",
month = "6",
day = "2",
doi = "10.1002/jhm.393",
language = "English (US)",
volume = "4",
pages = "28--34",
journal = "Journal of hospital medicine (Online)",
issn = "1553-5606",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Evaluation of glycemic control following discontinuation of an intensive insulin protocol

AU - Czosnowski, Quinn A.

AU - Swanson, Joseph

AU - Lobo, Bob L.

AU - Broyles, Joyce

AU - Deaton, Paul R.

AU - Finch, Christopher K.

PY - 2009/6/2

Y1 - 2009/6/2

N2 - Backgrounds: Intensive insulin protocols (IIPs) have been demonstrated to reduce morbidity and mortality in critically ill patients. Currently, there are no published studies evaluating glycemic control after discontinuation of an IIP. Objective: The purpose of this study was to compare blood glucose (BG) control during an IIP and for 5 days following its discontinuation (follow-up period). Methods: The study was a retrospective review of intensive care unit patients who received an IIP for ≥24 hours. Data were collected during the last 12 hours of the IIP and subsequent follow-up period. Results: For all 65 included patients, the mean ± standard deviation for BG on the IIP was 123 ± 26 mg/dL versus 168 ± 50 mg/dL following discontinuation of the IIP (P < 0.001). The median (interquartile range) insulin that was administered decreased from 40 (22-65) units on the IIP to 8 (0-18) units after the IIP was stopped (P < 0.001). The mean daily BG during the follow-up period was significantly higher than that during the IIP (P < 0.001). Additionally, an insulin requirement of >20 units during the last 12 hours of the IIP was identified as a risk factor for poor glycemic control during the follow-up period (odds ratio: 4.62; 95% confidence interval: 1.17-18.17). Conclusions: This study demonstrates a significant increase in BG following discontinuation of an IIP. Higher insulin requirements during the last 12 hours of an IIP were identified as an independent risk factor for poor glycemic control following the IIP. A standardized insulin transition protocol may help better control BG after discontinuation of an IIP.

AB - Backgrounds: Intensive insulin protocols (IIPs) have been demonstrated to reduce morbidity and mortality in critically ill patients. Currently, there are no published studies evaluating glycemic control after discontinuation of an IIP. Objective: The purpose of this study was to compare blood glucose (BG) control during an IIP and for 5 days following its discontinuation (follow-up period). Methods: The study was a retrospective review of intensive care unit patients who received an IIP for ≥24 hours. Data were collected during the last 12 hours of the IIP and subsequent follow-up period. Results: For all 65 included patients, the mean ± standard deviation for BG on the IIP was 123 ± 26 mg/dL versus 168 ± 50 mg/dL following discontinuation of the IIP (P < 0.001). The median (interquartile range) insulin that was administered decreased from 40 (22-65) units on the IIP to 8 (0-18) units after the IIP was stopped (P < 0.001). The mean daily BG during the follow-up period was significantly higher than that during the IIP (P < 0.001). Additionally, an insulin requirement of >20 units during the last 12 hours of the IIP was identified as a risk factor for poor glycemic control during the follow-up period (odds ratio: 4.62; 95% confidence interval: 1.17-18.17). Conclusions: This study demonstrates a significant increase in BG following discontinuation of an IIP. Higher insulin requirements during the last 12 hours of an IIP were identified as an independent risk factor for poor glycemic control following the IIP. A standardized insulin transition protocol may help better control BG after discontinuation of an IIP.

UR - http://www.scopus.com/inward/record.url?scp=66049089133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66049089133&partnerID=8YFLogxK

U2 - 10.1002/jhm.393

DO - 10.1002/jhm.393

M3 - Article

VL - 4

SP - 28

EP - 34

JO - Journal of hospital medicine (Online)

JF - Journal of hospital medicine (Online)

SN - 1553-5606

IS - 1

ER -